BioSystem Development

By Adam Bonislawski
Agilent Technologies and Integrated Diagnostics said this week that they have entered a strategic partnership to develop mass spec workflows for protein biomarker diagnostics.

By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – Agilent Technologies today said that it has completed the acquisition of BioSystem Development for an undisclosed sum.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Agilent Technologies today announced two deals that are expected to grow its footprint in the life science space.

The firm, which makes the AssayMap platform, plans to use the funds to scale up its manufacturing capabilities, increase the speed to market of its new products, and support expansion of its product pipeline.

Agilent will integrate mass-tagged PCR primers with LC-MS to enable the rapid identification of food-borne pathogens in one deal with UC-Davis, and combine its automated liquid handling platform with BioSystem's AssayMap high-throughput micro-chromatography technology in another collaboration.

The firms are combining their respective technologies to provide a platform that they said could process hundreds of samples in three hours or less.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.